Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
Muscarinic acetylcholine receptors (mAChRs), M(1)-M(5), regulate the activity of numerous fundamental central and peripheral functions. The lack of small-molecule ligands that can block or activate specific mAChR subtypes with high selectivity has remained a major obstacle in defining the roles of the individual receptor subtypes and in the development of novel muscarinic drugs. Recently, phenotypic analysis of mutant mouse strains deficient in each of the five mAChR subtypes has led to a wealth of new information regarding the physiological roles of the individual receptor subtypes. Importantly, these studies have identified specific mAChR-regulated pathways as potentially novel targets for the treatment of various important disorders including Alzheimer's disease, schizophrenia, pain, obesity and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Gq/11-coupled M1, M3 and M5 mAChRs elicit Ca2+ release from the endoplasmic reticulum (ER) by activating the downstream phospholipase C/inositol 1,4,5-trisphosphate/inositol 1,4,5-trisphosphate receptor (PLC/IP3/IP3R) cascade49, the same pathway triggered by TCR signaling.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [49]
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Abrams, P., Andersson, K., Buccafusco, J. J., Chapple, C., de Groat, W. C., Fryer, A. D., Kay, G., Laties, A., Nathanson, N. M., Pasricha, P. J., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706780 · Cited by 632
Molecular Psychology: Roles for the ERK MAP Kinase Cascade in Memory
Adams, J. P., & Sweatt, J. D. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.145401 · Cited by 593
New insights into sympathetic regulation of glucose and fat metabolism
Nonogaki, K. (2000) · Diabetologia · doi:10.1007/s001250051341 · Cited by 575
Muscarinic receptor subtypes and smooth muscle function
Eglen, R., Hegde, S., & Watson, N. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06957-1 · Cited by 544
Self-citationSelective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., & Silva, A. J. (2003) · Nature Neuroscience · doi:10.1038/nn992 · Cited by 544
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic β-Cell Function
Gilon, P., & Henquin, J.-C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0440 · Cited by 508
Molecular Biology of Muscarinic Acetylcholine Receptors
Wess, J. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i1.40 · Cited by 488
Self-citationDrug effects on salivary glands: dry mouth
Scully CBE, C. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.03967.x · Cited by 472
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
Di Chiara, G., Morelli, M., & Consolo, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90005-1 · Cited by 467
Matsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I., & Taketo, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9579 · Cited by 450
Levey, A. I. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90300-r · Cited by 448
M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice
Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., & LaFerla, F. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.020 · Cited by 417
Oakman, S., Faris, P., Kerr, P., Cozzari, C., & Hartman, B. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-05859.1995 · Cited by 384
Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications
Wess, J. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121622 · Cited by 380
Self-citationMice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C. J., Xia, B., Crawley, J. N., et al. (2001) · Nature · doi:10.1038/35065604 · Cited by 373
Self-citationMiyakawa, T., Yamada, M., Duttaroy, A., & Wess, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05239.2001 · Cited by 370
Self-citationHamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L., & Nathanson, N. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13311 · Cited by 366
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
Gomeza, J., Shannon, H., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H., & Wess, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1692 · Cited by 348
Self-citationCurrent Pharmacotherapy for Alzheimer's Disease
Lleó, A., Greenberg, S. M., & Growdon, J. H. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131442 · Cited by 345
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
Bernard, V, Normand, E., & Bloch, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03591.1992 · Cited by 327
Gomeza, J., Zhang, L., Kostenis, E., Felder, C., Bymaster, F., Brodkin, J., Shannon, H., Xia, B., Deng, C.-X., & Wess, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10483 · Cited by 322
Self-citationZhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., & Wess, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01709.2002 · Cited by 315
Self-citationMuscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
Eglen, R. M. (2006) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8673.2006.00368.x · Cited by 311
Self-citationGautam, D., Han, S.-J., Hamdan, F. F., Jeon, J., Li, B., Li, J. H., Cui, Y., Mears, D., Lu, H., Deng, C., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.009 · Cited by 299
Self-citationMuscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus
Volpicelli, L. A., & Levey, A. I. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45003-6 · Cited by 298
Sur, C., Mallorga, P. J., Wittmann, M., Jacobson, M. A., Pascarella, D., Williams, J. B., Brandish, P. E., Pettibone, D. J., Scolnick, E. M., & Conn, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835612100 · Cited by 294
Towards a muscarinic hypothesis of schizophrenia
Raedler, T. J., Bymaster, F. P., Tandon, R., Copolov, D., & Dean, B. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001924 · Cited by 291
Yamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C.-X., Faraci, F. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251542998 · Cited by 275
Self-citationMarino, M. J., Rouse, S. T., Levey, A. I., Potter, L. T., & Conn, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11465 · Cited by 275
Understanding salivary fluid and protein secretion
Turner, R. J., & Sugiya, H. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.2002.10815.x · Cited by 272
Vilaró, M. T., Palacios, J., & Mengod, G. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90064-g · Cited by 268
Gerber, D. J., Sotnikova, T. D., Gainetdinov, R. R., Huang, S. Y., Caron, M. G., & Tonegawa, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261583798 · Cited by 264
GPCR interacting proteins (GIP)
Bockaert, J., Fagni, L., Dumuis, A., & Marin, P. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.004 · Cited by 263
Muscarinic receptor subtypes in airways
Barnes, P. J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90310-y · Cited by 255
Weiner, D. M., Meltzer, H. Y., Veinbergs, I., Donohue, E. M., Spalding, T. A., Smith, T. T., Mohell, N., Harvey, S. C., Lameh, J., Nash, N., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1940-5 · Cited by 253
Fisahn, A., Yamada, M., Duttaroy, A., Gan, J.-W., Deng, C.-X., McBain, C. J., & Wess, J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00587-1 · Cited by 252
Self-citationShinoe, T., Matsui, M., Taketo, M. M., & Manabe, T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2338-05.2005 · Cited by 241
Fukudome, Y., Ohno‐Shosaku, T., Matsui, M., Omori, Y., Fukaya, M., Tsubokawa, H., Taketo, M. M., Watanabe, M., Manabe, T., & Kano, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03384.x · Cited by 238
Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
Felder, C. C., Bymaster, F. P., Ward, J., & DeLapp, N. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990607u · Cited by 235
Muscarinic receptors in the bladder: from basic research to therapeutics
Hegde, S. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706560 · Cited by 232
Seeger, T., Fedorova, I., Zheng, F., Miyakawa, T., Koustova, E., Gomeza, J., Basile, A. S., Alzheimer, C., & Wess, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3581-04.2004 · Cited by 214
Self-citationMuscarinic Receptor Subtype Pharmacology and Physiology
Eglen, R. M. (2005) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(05)43004-0 · Cited by 213
Self-citationMatsui, M., Motomura, D., Fujikawa, T., Jiang, J., Takahashi, S.-I., Manabe, T., & Taketo, M. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10627.2002 · Cited by 213
Quirion, R., Wilson, A., Rowe, W., Aubert, I., Richard, J., Doods, H., Parent, A., White, N., & Meaney, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01455.1995 · Cited by 205
Duttaroy, A., Zimliki, C. L., Gautam, D., Cui, Y., Mears, D., & Wess, J. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1714 · Cited by 199
Self-citationMuscarinic acetylcholine receptors and airway diseases
Coulson, F. R., & Fryer, A. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00004-4 · Cited by 196
Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162371899 · Cited by 195
Self-citationDiscovery of an Ectopic Activation Site on the M1Muscarinic Receptor
Spalding, T. A., Trotter, C., Skjærbæk, N., Messier, T. L., Currier, E. A., Burstein, E. S., Li, D., Hacksell, U., & Brann, M. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12088-3 · Cited by 193
Tzavara, E. T., Bymaster, F. P., Davis, R. J., Wade, M. R., Perry, K. W., Wess, J., McKinzie, D. L., Felder, C., & Nomikos, G. G. (2004) · The FASEB Journal · doi:10.1096/fj.04-1575fje · Cited by 191
Self-citationM2 and M4 Receptor Knockout Mice: Muscarinic Receptor Function in Cardiac and Smooth Muscle In Vitro
Stengel, P. W., Gomeza, J., Wess, J., & Cohen, M. L. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35366-2 · Cited by 190
Self-citationNakamura, T., Matsui, M., Uchida, K., Futatsugi, A., Kusakawa, S., Matsumoto, N., Nakamura, K., Manabe, T., Taketo, M. M., & Mikoshiba, K. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.064626 · Cited by 189
The Non-neuronal Cholinergic System of Human Skin
Kurzen, H., Wessler, I., Kirkpatrick, C., Kawashima, K., & Grando, S. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-961816 · Cited by 189
Ince, E., Ciliax, B. J., & Levey, A. I. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<357::aid-syn9>3.0.co;2-b · Cited by 175
Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors
Lanzafame, A. A., Christopoulos, A., & Mitchelson, F. J. (2003) · Receptors and Channels · doi:10.3109/10606820308263 · Cited by 174
Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., & Brandeis, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:349 · Cited by 173
Therapeutic opportunities from muscarinic receptor research
Eglen, R. M., Choppin, A., & Watson, N. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01737-5 · Cited by 169
Self-citationOhno‐Shosaku, T., Matsui, M., Fukudome, Y., Shosaku, J., Tsubokawa, H., Taketo, M. M., Manabe, T., & Kano, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02732.x · Cited by 166
Tzavara, E. T., Bymaster, F. P., Felder, C. C., Wade, M., Gomeza, J., Wess, J., McKinzie, D. L., & Nomikos, G. G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001270 · Cited by 163
Self-citationGautam, D., Heard, T. S., Cui, Y., Miller, G., Bloodworth, L. M., & Wess, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.260 · Cited by 155
Self-citationForster, G. L., Yeomans, J. S., Takeuchi, J., & Blaha, C. D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-j0001.2002 · Cited by 152
Iwamoto, E. T., & Marion, L. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38297-2 · Cited by 145
Attention deficit/hyperactivity disorder: characteristics, interventions and models
Paule, M. G., Rowland, A. S., Ferguson, S. A., Chelonis, J. J., Tannock, R., Swanson, J. M., & Castellanos, F. X. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(00)00095-7 · Cited by 145
Role for M 5 muscarinic acetylcholine receptors in cocaine addiction
Fink‐Jensen, A., Fedorova, I. D., Wörtwein, G., Woldbye, D. P. D., Rasmussen, T., Thomsen, M., Bolwig, T. G., Knitowski, K. M., McKinzie, D. L., Yamada, M., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10728 · Cited by 141
Self-citationDuttaroy, A., Gomeza, J., Gan, J.-W., Siddiqui, N., Basile, A. S., Harman, W. D., Smith, P. L., Felder, C. C., Levey, A. I., & Wess, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1084 · Cited by 141
Self-citationMuscarinic Receptors as a Target for Drugs Treating Schizophrenia
Bymaster, F. P., Felder, C. C., Ahmed, S., & McKinzie, D. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007024606249 · Cited by 131
Stengel, P. W., Yamada, M., Wess, J., & Cohen, M. L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00486.2001 · Cited by 129
Self-citationThe management of Sjögren's syndrome
Mavragani, C. P., Moutsopoulos, N. M., & Moutsopoulos, H. Μ. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0165 · Cited by 127
Fisher, J. T., Vincent, S. G., Gomeza, J., Yamada, M., & Wess, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0648fje · Cited by 127
Self-citationAllosterism at Muscarinic Receptors: Ligands and Mechanisms
Birdsall, N. J. M., & Lazareno, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054023251 · Cited by 126
A multiplicity of muscarinic mechanisms: Enough signaling pathways to take your breath away
Nathanson, N. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6245 · Cited by 122
Reduced Cocaine Self-Administration in Muscarinic M5Acetylcholine Receptor-Deficient Mice
Thomsen, M., Woldbye, D. P. D., Wörtwein, G., Fink‐Jensen, A., Wess, J., & Caine, S. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2077-05.2005 · Cited by 121
Self-citationElucidating the role of muscarinic receptors in psychosis
Felder, C. C., Porter, A. C., Skillman, T. L., Zhang, L., Bymaster, F. P., Nathanson, N. M., Hamilton, S. E., Gomeza, J., Wess, J., & McKinzie, D. L. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01059-1 · Cited by 120
Self-citationStruckmann, N., Schwering, S., Wiegand, S., Gschnell, A., Yamada, M., Kummer, W., Wess, J., & Haberberger, R. V. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1444 · Cited by 119
Self-citationExcitatory Nicotinic and Desensitizing Muscarinic (M2) Effects on C-Nociceptors in Isolated Rat Skin
Bernardini, N., Sauer, S. K., Haberberger, R. V., Fischer, M. J. M., & Reeh, P. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03295.2001 · Cited by 114
Muscarinic receptors involved in hippocampal plasticity
Segal, M., & Auerbach, J. M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00051-9 · Cited by 109
Altered Hippocampal Muscarinic M4, but Not M1, Receptor Expression from Subjects with Schizophrenia
Scarr, E., Sundram, S., Keriakous, D., & Dean, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.050 · Cited by 108
Langmead, C. J., Fry, V. A. H., Forbes, I. T., Branch, C. L., Christopoulos, A., Wood, M. D., & Herdon, H. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017814 · Cited by 108
Lazareno, S., Doležal, V., Popham, A., & Birdsall, N. J. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.257 · Cited by 104
Snake toxins with high selectivity for subtypesof muscarinic acetylcholine receptors
Karlsson, E. (2000) · Biochimie · doi:10.1016/s0300-9084(00)01176-7 · Cited by 103
Use of Muscarinic Agonists in the Treatment of Sjögren's Syndrome
Fox, R. I., Konttinen, Y. T., & Fisher, A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5128 · Cited by 101
Araya, R., Noguchi, T., Yuhki, M., Kitamura, N., Higuchi, M., Saido, T. C., Seki, K., Itohara, S., Kawano, M., Tanemura, K., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.010 · Cited by 100
Self-citationHamilton, S. E., & Nathanson, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011563200 · Cited by 100
Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency
Gautam, D., Gavrilova, O., Jeon, J., Pack, S., Jou, W., Cui, Y., Li, J. H., & Wess, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.09.008 · Cited by 99
Self-citationBerkeley, J. L., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., & Levey, A. I. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1042 · Cited by 98 · cited 1×
“or CA1 hippocampal pyramidal neurons from M1R −/− mic”
BackgroundSelf-citationUnno, T., Matsuyama, H., Sakamoto, T., Uchiyama, M., Izumi, Y., Okamoto, H. H., Yamada, M., Wess, J., & Komori, S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706300 · Cited by 95
Self-citationMuscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
Quirion, R., Aubert, I., Lapchak, P. A., Schaum, R. P., Teolis, S., Gauthier, S. G., & Araujo, D. M. (1989) · PubMed · Cited by 95
Functional analysis of muscarinic acetylcholine receptors using knockout mice
Matsui, M., Yamada, S., Oki, T., Manabe, T., Taketo, M. M., & Ehlert, F. J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.034 · Cited by 92
Chernyavsky, A. I., Arredondo, J., Wess, J., Karlsson, E., & Grando, S. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401034 · Cited by 92
Self-citationMuscarinic M2 Receptors on Peripheral Nerve Endings: A Molecular Target of Antinociception
Bernardini, N., Roza, C., Sauer, S. K., Gomeza, J., Wess, J., & Reeh, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-j0002.2002 · Cited by 85
Self-citationNguyen, V. T., Chernyavsky, A. I., Arredondo, J., Bercovich, D., Orr‐Urtreger, A., Vetter, D. E., Wess, J., Beaudet, A. L., Kitajima, Y., & Grando, S. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.010 · Cited by 85
Self-citationNeural Mechanisms in the Control of Blood Glucose Concentration
Niijima, A. (1989) · Journal of Nutrition · doi:10.1093/jn/119.6.833 · Cited by 82
Cholinergic mechanisms in pain and analgesia.
Hartvig, P., Gillberg, P.-G., Gordh, T., & Post, C. (1989) · PubMed · Cited by 79
Carey, G. J., Billard, W., Binch, H., Cohen-Williams, M. E., Crosby, G., Grzelak, M. J., Guzik, H. S., Kozlowski, J. A., Lowe, D., Pond, A. J., et al. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01440-6 · Cited by 77
Development of Muscarinic Analgesics Derived from Epibatidine: Role of the M4 Receptor Subtype
Ellis, J. L., Harman, D., González‐Gallego, J., Spera, M. L., Liu, R., Shen, T. Y., Wypij, D. M., & Zuo, F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38067-x · Cited by 71
Matsui, M., Griffin, M. T., Shehnaz, D., Taketo, M. M., & Ehlert, F. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044701 · Cited by 67
Wang, H., Ng, K. K. Y., Hayes, D. J., Gao, X., Forster, G. L., Blaha, C. D., & Yeomans, J. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300502 · Cited by 60
Origlia, N., Kuczewski, N., Aztiria, E., Gautam, D., Wess, J., & Domenici, L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.117119 · Cited by 58
Self-citationUnno, T., Matsuyama, H., Izumi, Y., Yamada, M. K., Wess, J., & Komori, S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706955 · Cited by 55
Self-citationTherapeutic potential of thromboxane inhibitors in asthma
Pirotte, B., Benoit, P., Dogné, J.-M., Masereel, B., Rolin, S., & de Leval, X. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.2.275 · Cited by 55
Aihara, T., Fujishita, T., Kanatani, K., Furutani, K., Nakamura, E., Taketo, M. M., Matsui, M., Chen, D., & Okabe, S. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.018 · Cited by 52
Cholinergic Agonists and the Treatment of Alzheimers Disease
Messer, W. S. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607553 · Cited by 51
Allen, I. C., Hartney, J. M., Coffman, T. M., Penn, R. B., Wess, J., & Koller, B. H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00340.2005 · Cited by 49
Self-citationAihara, T., Nakamura, Y., Taketo, M. M., Matsui, M., & Okabe, S. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00514.2004 · Cited by 49
Scanning Mutagenesis Studies of the M 1 Muscarinic Acetylcholine Receptor
Hulme, E. C., Lu, Z.-L., & Bee, M. S. (2003) · Receptors and Channels · doi:10.1080/10606820308261 · Cited by 47
Karasawa, H., Taketo, M. M., & Matsui, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01642-x · Cited by 46
Rowe, W. B., O’Donnell, J.-P., Pearson, D., Rose, G. M., Meaney, M. J., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00116-5 · Cited by 46
Muscarinic M2 receptors inhibit heat-induced CGRP release from isolated rat skin
Bernardini, N., Reeh, P. W., & Sauer, S. K. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00034 · Cited by 45
Chen, S.-R., Wess, J., & Pan, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082537 · Cited by 44
Self-citationEffects of muscarinic receptor type 3 knockout on mouse islet secretory responses
Zawalich, W. S., Zawalich, K. C., Tesz, G. J., Taketo, M. M., Sterpka, J., Philbrick, W. M., & Matsui, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.139 · Cited by 43
Kitaichi, K., Hori, T., Srivastava, L. K., & Quirion, R. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00047-9 · Cited by 43
Thomsen, M., Wörtwein, G., Fink‐Jensen, A., Woldbye, D. P. D., Wess, J., & Caine, S. B. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0682-y · Cited by 41
Self-citationSnake toxins that bind specifically to individual subtypes of muscarinic receptors
Potter, L. T. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01050-5 · Cited by 41
Guo, Y., Traurig, M. T., Ma, L., Kobes, S., Harper, I., Infante, A. M., Bogardus, C., Baier, L. J., & Procházka, M. (2006) · Diabetes · doi:10.2337/db06-0379 · Cited by 41
Stengel, P. W., & Cohen, M. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.643 · Cited by 39
Lachowicz, J. E., Duffy, R. A., Ruperto, V., Kozlowski, J. A., Zhou, G., Clader, J. W., Billard, W., Binch, H., Crosby, G., Cohen-Williams, M. E., et al. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01056-6 · Cited by 38
Increased drinking in mutant mice with truncated M5 muscarinic receptor genes
Takeuchi, J., Fulton, J., Jia, Z., Abramow-Newerly, W., Jamot, L., Sud, M., Coward, D. M., Ralph, M. R., Roder, J., & Yeomans, J. S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00725-0 · Cited by 37
Zhang, Y. F., Hamilton, S. E., Nathanson, N. M., & Yan, J. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhj067 · Cited by 35
Butylthio[2.2.2] (NNC 11–1053/LY297802): An Orally Active Muscarinic Agonist Analgesic
Swedberg, M. D. B., Sheardown, M. J., Sauerberg, P., Olesen, P. H., Suzdak, P. D., Hansen, K. T., Bymaster, F. P., Ward, J. S., Mitch, C. H., Calligaro, D. O., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36644-3 · Cited by 31
Kitazawa, T., Hashiba, K., Cao, J., Unno, T., Komori, S., Yamada, M., Wess, J., & Taneike, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.013 · Cited by 27
Self-citationScanning Mutagenesis Studies of the M 1 Muscarinic Acetylcholine Receptor
Hulme, E. C., Lu, Z.-L., & Bee, M. S. (2003) · Receptors and Channels · doi:10.3109/10606820308261 · Cited by 21
Nishiyama, T., Nakamura, T., Obara, K., Inoue, H., Mishima, K., Matsumoto, N., Matsui, M., Manabe, T., Mikoshiba, K., & Saito, I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113092 · Cited by 14
Cited by
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citation
Metadata
- Authors
- Wess, J., Eglen, R. M., & Gautam, D.
- Affiliations
- National Institutes of Health (US)
- PerkinElmer (United States) (US)
- Corresponding author
- Wess, Jürgen
- ORCID
- Wess, Jürgen
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-09
- Volume
- 6
- Issue
- 9
- Pages
- 721-733
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1999774383
- Cited by
- 637
- References
- 134
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 23 · 2019: 29 · 2018: 36 · 2017: 32 · 2016: 38 · 2015: 26 · 2014: 45 · 2013: 40 · 2012: 43
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- muscarinic receptors, knockout mice, Alzheimer's disease, schizophrenia, pain, obesity, diabetes mellitus, receptor function
- MeSH terms
- Animals, Disease Models, Animal, Ligands, Receptors, Muscarinic, Drug Design, Mice, Knockout, Muscarinic Agonists, Muscarinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.